Related Experiment Video
Updated: Mar 24, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
The ROCKs on which tumour cells thrive
Simon Wilkinson1, Margaret C Frame1
1CRUK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
New research shows that ROCK proteins are crucial for tumor development in mice. Understanding these proteins could lead to new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Rho-associated coiled-coil containing protein kinases (ROCK) are known regulators of the actin cytoskeleton.
- Dysregulation of ROCK signaling has been implicated in various diseases, including cancer.
Purpose of the Study:
- To investigate the role of ROCK proteins in tumor formation and progression.
- To determine the specific mechanisms by which ROCK proteins influence tumorigenesis.
Main Methods:
- Utilized genetically engineered mouse models to study tumor development.
- Employed molecular biology techniques, including Western blotting and immunohistochemistry, to analyze protein expression and activity.
- Assessed tumor growth, metastasis, and overall survival in the mouse models.
Main Results:
- ROCK proteins were found to be significantly upregulated in tumor tissues compared to normal tissues.
- Inhibition of ROCK activity led to reduced tumor growth and decreased incidence of metastasis in mice.
- ROCK signaling was shown to promote cancer cell proliferation, migration, and invasion.
Conclusions:
- ROCK proteins are key drivers of tumor formation and progression in mice.
- Targeting ROCK signaling pathways presents a potential therapeutic strategy for cancer treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Receptor Tyrosine Kinases

